HIV facial lipoatrophy: causes and treatment options.

BACKGROUND

Human immunodeficiency virus (HIV)-associated facial lipoatrophy is becoming epidemic and may seriously affect quality of life.

OBJECTIVE

To review the possible causes and treatment options for HIV facial lipoatrophy.

METHODS

This article is based on a review of the medical literature and the author's clinical experience in treating HIV facial

CONCLUSION

Although absorbable injectable fillers and implants are helpful in treating HIV facial lipoatrophy, they are limited by cost and the short duration of correction. Newer forms of longer-lasting fillers (poly-L-lactic acid [Sculptra]) and permanent injectable fillers (liquid injectable silicone) are proving useful for treatment of this condition.